Renvela Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
Condition:   Hyperphosphatemia Interventions:   Drug: EOS789;   Drug: Placebo;   Drug: Renvela Sponsor:   Chugai Pharmaceutical Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2016 Category: Research Source Type: clinical trials